Reback C, Blue T, Jalali A, Landovitz R, Li M, Mata R
JMIR Res Protoc. 2025; 14:e65313.
PMID: 39847410
PMC: 11803334.
DOI: 10.2196/65313.
Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E
Ann Emerg Med. 2024; 85(3):205-213.
PMID: 39570250
PMC: 11845297.
DOI: 10.1016/j.annemergmed.2024.10.001.
Kiburi S, Paruk S, Kwobah E, Chiliza B
PLOS Digit Health. 2023; 2(11):e0000375.
PMID: 37930956
PMC: 10627438.
DOI: 10.1371/journal.pdig.0000375.
Running Bear U, Poole E, Muller C, Hanson J, Noonan C, Trojan J
Public Health Pract (Oxf). 2023; 6:100418.
PMID: 37635913
PMC: 10448195.
DOI: 10.1016/j.puhip.2023.100418.
Vaca F, Dziura J, Abujarad F, Pantalon M, Hsiao A, Reynolds J
JAMA Netw Open. 2023; 6(5):e2314848.
PMID: 37219901
PMC: 10208138.
DOI: 10.1001/jamanetworkopen.2023.14848.
Computational analyses identify addiction help-seeking behaviors on the social networking website Reddit: Insights into online social interactions and addiction support communities.
Valdez D, Patterson M
PLOS Digit Health. 2023; 1(11):e0000143.
PMID: 36812569
PMC: 9931264.
DOI: 10.1371/journal.pdig.0000143.
Telehealth interventions for substance use disorders in low- and- middle income countries: A scoping review.
Ojeahere M, Kiburi S, Agbo P, Kumar R, Jaguga F
PLOS Digit Health. 2023; 1(11):e0000125.
PMID: 36812539
PMC: 9931245.
DOI: 10.1371/journal.pdig.0000125.
Cost-effectiveness of Internet Interventions Compared With Treatment as Usual for People With Mental Disorders: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Rohrbach P, Dingemans A, Evers C, van Furth E, Spinhoven P, Aardoom J
J Med Internet Res. 2023; 25:e38204.
PMID: 36602854
PMC: 9893732.
DOI: 10.2196/38204.
Preliminary efficacy of a digital therapeutics smartphone application for methamphetamine use disorder: An experimental study.
Zhang L, Li N, Li Y, Zhang T, Li D, Liu Y
Front Psychiatry. 2022; 13:1027695.
PMID: 36339836
PMC: 9627209.
DOI: 10.3389/fpsyt.2022.1027695.
Econometric Issues in Prospective Economic Evaluations Alongside Clinical Trials: Combining the Nonparametric Bootstrap With Methods That Address Missing Data.
Jalali A, Tamimi R, McPherson S, Murphy S
Epidemiol Rev. 2022; 44(1):67-77.
PMID: 36104860
PMC: 10362933.
DOI: 10.1093/epirev/mxac006.
Cost-effectiveness of extended-release injectable naltrexone among incarcerated persons with opioid use disorder before release from prison versus after release.
Jalali A, Jeng P, Polsky D, Poole S, Ku Y, Woody G
J Subst Abuse Treat. 2022; 141:108835.
PMID: 35933942
PMC: 9508988.
DOI: 10.1016/j.jsat.2022.108835.
Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomized clinical trial of integrated outpatient treatment of opioid use disorder and severe, injection-related infections.
Fanucchi L, Murphy S, Surratt H, Kapadia S, Walsh S, Grubbs J
Ther Adv Infect Dis. 2022; 9:20499361221108005.
PMID: 35847566
PMC: 9277431.
DOI: 10.1177/20499361221108005.
Digital interventions in mental health: evidence syntheses and economic modelling.
Gega L, Jankovic D, Saramago P, Marshall D, Dawson S, Brabyn S
Health Technol Assess. 2022; 26(1):1-182.
PMID: 35048909
PMC: 8958412.
DOI: 10.3310/RCTI6942.
Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale.
Perez-Correa A, Abbas B, Riback L, Ghiroli M, Norton B, Murphy S
Contemp Clin Trials. 2022; 114:106674.
PMID: 34990854
PMC: 10123766.
DOI: 10.1016/j.cct.2021.106674.
Contingency management for alcohol use disorder reduces cannabis use among American Indian and Alaska Native adults.
Hirchak K, Lyons A, Herron J, Kordas G, Shaw J, Jansen K
J Subst Abuse Treat. 2021; 137:108693.
PMID: 34952747
PMC: 9086134.
DOI: 10.1016/j.jsat.2021.108693.
Integrating traditional practices and social network visualization to prevent substance use: study protocol for a randomized controlled trial among urban Native American emerging adults.
DAmico E, Dickerson D, Rodriguez A, Brown R, Kennedy D, Palimaru A
Addict Sci Clin Pract. 2021; 16(1):56.
PMID: 34565444
PMC: 8474938.
DOI: 10.1186/s13722-021-00265-3.
Trial study design to test a bilingual digital health tool for alcohol use disorders among Latino emergency department patients.
Vaca F, Dziura J, Abujarad F, Pantalon M, Hsiao A, Field C
Contemp Clin Trials. 2020; 97:106128.
PMID: 32950400
PMC: 7721867.
DOI: 10.1016/j.cct.2020.106128.
Trial study design to test a bilingual digital health tool for alcohol use disorders among Latino emergency department patients.
Vaca F, Dziura J, Abujarad F, Pantalon M, Hsiao A, Field C
Contemp Clin Trials. 2020; 96:106104.
PMID: 32777381
PMC: 8252296.
DOI: 10.1016/j.cct.2020.106104.
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.
Murphy S, Jeng P, Poole S, Jalali A, Vocci F, Gordon M
Addict Sci Clin Pract. 2020; 15(1):15.
PMID: 32321570
PMC: 7178627.
DOI: 10.1186/s13722-020-00188-5.
The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
Marsch L, Campbell A, Campbell C, Chen C, Ertin E, Ghitza U
J Subst Abuse Treat. 2020; 112S:4-11.
PMID: 32220409
PMC: 7134325.
DOI: 10.1016/j.jsat.2020.02.005.